Correlation Between Q32 Bio and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Q32 Bio and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q32 Bio and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Q32 Bio and Seres Therapeutics, you can compare the effects of market volatilities on Q32 Bio and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q32 Bio with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q32 Bio and Seres Therapeutics.
Diversification Opportunities for Q32 Bio and Seres Therapeutics
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Q32 and Seres is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Q32 Bio and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Q32 Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q32 Bio are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Q32 Bio i.e., Q32 Bio and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Q32 Bio and Seres Therapeutics
Given the investment horizon of 90 days Q32 Bio is expected to generate 0.77 times more return on investment than Seres Therapeutics. However, Q32 Bio is 1.3 times less risky than Seres Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 2,880 in Q32 Bio on September 3, 2024 and sell it today you would lose (189.00) from holding Q32 Bio or give up 6.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Q32 Bio vs. Seres Therapeutics
Performance |
| Timeline |
| Q32 Bio |
| Seres Therapeutics |
Q32 Bio and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Q32 Bio and Seres Therapeutics
The main advantage of trading using opposite Q32 Bio and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q32 Bio position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Q32 Bio vs. DiaMedica Therapeutics | Q32 Bio vs. Lyra Therapeutics | Q32 Bio vs. Centessa Pharmaceuticals PLC |
| Seres Therapeutics vs. DiaMedica Therapeutics | Seres Therapeutics vs. Lyra Therapeutics | Seres Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |